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Background: Controversy remains over the optimal timing of percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial 
infarction (STEMI) who have initially been treated with fibrinolytic agents.
Methods: We performed a meta-analysis of studies comparing immediate or early angiography after fibrinolysis versus a more conservative strategy 
of deferred PCI or ischemia-guided management.
Results: The search strategy identified 9 contemporary randomised controlled trials eligible for inclusion enrolling a total of 3325 patients. Follow-
up ranged between 1 and 12 months. An immediate or early invasive strategy reduced non-fatal myocardial reinfarction as compared with deferred 
angiography or ischemia-guided management (risk ratio [RR] 0.58 [95% CI 0.41 to 0.75], p<0.001). A trend towards a mortality benefit with 
immediate or early PCI was observed (81 vs 105 deaths, RR 0.76 [95% CI 0.58 to 1.01], p=0.06). There were no significant differences in the risk of 
stroke or major bleeding.
Conclusion: An immediate or early invasive strategy after fibrinolytic therapy is associated with a significant reduction in the short-term risk of 
non-fatal myocardial reinfarction without an excess in complications. These results support the current recommendation of a routine early invasive 
strategy in STEMI patients after fibrinolysis.
